<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=The_Controversy_Over_Callous_flupentixol-Approaches</id>
		<title>The Controversy Over Callous flupentixol-Approaches - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=The_Controversy_Over_Callous_flupentixol-Approaches"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_Controversy_Over_Callous_flupentixol-Approaches&amp;action=history"/>
		<updated>2026-06-20T10:29:58Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=The_Controversy_Over_Callous_flupentixol-Approaches&amp;diff=152555&amp;oldid=prev</id>
		<title>Bronzeedge83: Створена сторінка: None of the children in group A and B had IgE antibodies to LTP, i.e. Pru p 3. Figure?1 shows IgE reactivity to Ara h 1, 2, 3 and 8, Bet v 1, profilin and CCD i...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_Controversy_Over_Callous_flupentixol-Approaches&amp;diff=152555&amp;oldid=prev"/>
				<updated>2017-03-15T02:44:53Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: None of the children in group A and B had IgE antibodies to LTP, i.e. Pru p 3. Figure?1 shows IgE reactivity to Ara h 1, 2, 3 and 8, Bet v 1, profilin and CCD i...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;None of the children in group A and B had IgE antibodies to LTP, i.e. Pru p 3. Figure?1 shows IgE reactivity to Ara h 1, 2, 3 and 8, Bet v 1, profilin and CCD in relation to reported symptoms to peanut. IgE reactivity to the peanut storage proteins (Ara h 1, 2 and 3) was present only in children sensitized to peanut (group A and B), whereas 11 children in group C (birch pollen sensitized only) had IgE reactivity [http://www.selleckchem.com/products/ipi-145-ink1197.html Duvelisib clinical trial] to Ara h 8. Among the Ara h 8 sensitized children, all but two had low to moderate IgE levels to Ara h 8 ([http://www.selleckchem.com/products/pfi-2.html PFI-2 nmr] significantly higher IgE antibody levels (geometric mean, 95% CI) to peanut (18.9?kUA/l, 11.5�C31.0?kUA/l, n?=?46) than children with reactivity to Ara h 8 only (1.0?kUA/l, 0.60�C1.7?kUA/l, n?=?23). Of the 100 peanut-sensitized children (group A and B), 25 were IgE negative to all tested peanut components in the microarray including CCD and profilin. In 17 of these 25 children, the peanut-specific IgE levels were below 1?kUA/l (Fig.?2). Seven of the negative children had responses to one or more peanut-related components in the microarray just below the cut-off level (data not shown). Symptoms to peanut were more common in peanut-sensitized children without concomitant birch pollen sensitization (group A: 74%, 95% CI 60�C85%) than in children sensitized to both peanut and birch pollen: (group B: 43%, 95% CI 29�C58%). In birch pollen-sensitized children without sensitization to peanut, reported symptoms to peanut was less common [https://en.wikipedia.org/wiki/Flupentixol flupentixol] (group C: 8%, 95% CI 2�C20%). None of the children sensitized neither to peanut nor to birch pollen (group D) reported symptoms to peanut (Fig.?1). When children in groups A�CD were regrouped according to whether they reported symptoms to peanut, 94% of those reporting peanut allergy, and 30% of the tolerant children, had peanut-specific IgE levels &amp;gt;0.35?kUA/l (Table?2). IgE reactivity to Ara h 1, 2 and 3 was much more common in children who reported peanut allergy than in tolerant children (P?&lt;/div&gt;</summary>
		<author><name>Bronzeedge83</name></author>	</entry>

	</feed>